Drawing for CLINECT

USPTO serial 79113881

CLINECT

Reviewed by CopyMark Law Group

Reg. 4307286Status 404
Filing date
Status date
Registration date
Mar 26, 2013
Examiner
ROSSMAN, WILLIAM M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CLINECT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nicole B. Emmons

Nicole B. Emmons Baker & McKenzie LLP2001 Ross Avenue2300 Trammell Crow CenterDallas, TX 75201

Goods and services

ClassDescriptionStatusFirst use
035Advertising; business management; business administration; providing office functions; retail pharmacy services; wholesaling and retailing store services featuring medications; business management services provided to franchisees and pharmacists within the framework of franchising, including in relation to standardisation of shop layout, provision of joint buying services, assistance in stocking and advertising activities and provision of advertising services; business management services provided to pharmacies particularly provided in on-line or electronic format including retail point of sale information services, inventory control and reordering services, inventory management services; retail store services featuring computer software and software applications relating to pharmacy dispensing; accountancy and advertising services; business information services; business support staff services; business administration and management advisory services; retail store services featuring computer software and hardware to pharmacists and franchiseesSECTION 71 - CANCELLED—
044Medical services; medical analysis for diagnostic and treatment purposes; pharmaceutical advisory services; dispensing of pharmaceuticals; provision of pharmaceutical advice; provision of pharmacy advice in relation to prescriptions; providing information and online information about medical and pharmaceutical services; providing rest and convalescent homes; providing medical centres and medical practices; medical and health care services including provision of medical diagnostic, imaging, pathology, general practitioner, and hospital services; veterinary services; hygienic and beauty care for human beings or animals; pest control services for agriculture, horticulture or forestrySECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 10, 2022DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jul 10, 2022DETHDEATH OF INTERNATIONAL REGISTRATION—
Sep 12, 2020INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Aug 16, 2020INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Aug 15, 2020INPCINVALIDATION PROCESSED—
Jul 1, 2020INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Nov 1, 2019C71TCANCELLED SECTION 71—
Mar 26, 2018REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 6, 2017ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jan 3, 2015NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 14, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 27, 2013FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 27, 2013FIMPFINAL DISPOSITION PROCESSED—
Jun 26, 2013FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 26, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 14, 2013GPNXNOTIFICATION PROCESSED BY IB—
Jan 8, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 8, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 19, 2012OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 19, 2012OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 19, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 1, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 26, 2012ALIEASSIGNED TO LIE—
Nov 7, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 1, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 31, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 31, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 4, 2012RFNTREFUSAL PROCESSED BY IB—
Jul 17, 2012RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 17, 2012RFRRREFUSAL PROCESSED BY MPU—
Jul 17, 2012RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 16, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 13, 2012MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 9, 2012DOCKASSIGNED TO EXAMINER—
Jul 9, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 6, 2012LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jul 5, 2012REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance